Home Cart Sign in  
Chemical Structure| 605-62-9 Chemical Structure| 605-62-9

Structure of KAT8-IN-1
CAS No.: 605-62-9

Chemical Structure| 605-62-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

KAT8-IN-1 is a lysine acetyltransferase 8 (KAT8) inhibitor, with IC50 values of 141 μM, 221 μM, and 106 μM for KAT8, KAT2B, and KAT3B, respectively.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of KAT8-IN-1

CAS No. :605-62-9
Formula : C10H7NO3
M.W : 189.17
SMILES Code : OC1=C2C=CC=CC2=C([N+]([O-])=O)C=C1
MDL No. :MFCD02179392
InChI Key :AUIRNGLMBHIITH-UHFFFAOYSA-N
Pubchem ID :343829

Safety of KAT8-IN-1

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
A549 cells 300 μM 14 hours To investigate the effect of KAT8-IN-1 on extracellular free fatty acids (FFAs) release Adv Sci (Weinh). 2024 Oct;11(38):e2406333
H1299 cells 300 μM 14 hours To investigate the effect of KAT8-IN-1 on extracellular free fatty acids (FFAs) release Adv Sci (Weinh). 2024 Oct;11(38):e2406333
KAT3B 200 μM To determine the inhibitory activity of KAT3B, compound 13 showed an IC50 of 1.4 ± 0.1 μM Eur J Med Chem. 2017 Aug 18;136:480-486
KAT2B 200 μM To determine the inhibitory activity of KAT2B, compound 13 showed an IC50 of 3.6 ± 1.1 μM Eur J Med Chem. 2017 Aug 18;136:480-486
KAT8 200 μM To determine the inhibitory activity of KAT8, 4-amino-1-naphthol (compound 13) was found to be a potent KAT8 inhibitor with an IC50 of 9.7 ± 3.0 μM Eur J Med Chem. 2017 Aug 18;136:480-486

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

5.29mL

1.06mL

0.53mL

26.43mL

5.29mL

2.64mL

52.86mL

10.57mL

5.29mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories